{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:32:31Z","timestamp":1793705551407,"version":"4.5.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/inf.0b013e31827e92b7","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T10:12:51Z","timestamp":1355825571000},"page":"530-537","source":"Crossref","is-referenced-by-count":37,"title":["Changes in Patterns of Hospitalized Children With Varicella and of Associated Varicella Genotypes After Introduction of Varicella Vaccine in Australia"],"prefix":"10.1097","volume":"32","author":[{"given":"Helen S.","family":"Marshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim P.","family":"Buttery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny A.","family":"Royle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Zurynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl S.","family":"Toi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic E.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Booy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-19-20210202","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/infdis\/172.3.706","article-title":"The epidemiology of varicella and its complications.","volume":"172","author":"Choo","year":"1995","journal-title":"J Infect Dis"},{"key":"R4-19-20210202","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1542\/peds.108.5.e79","article-title":"Severe complications of varicella in previously healthy children in Germany: a 1-year survey.","volume":"108","author":"Ziebold","year":"2001","journal-title":"Pediatrics"},{"key":"R5-19-20210202","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/adc.2010.206037","article-title":"Congenital and neonatal varicella: Impact of the national varicella immunisation program in Australia.","volume":"96","author":"Khandaker","year":"2011","journal-title":"Arch Dis Child"},{"key":"R6-19-20210202","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1467-842X.1998.tb01405.x","article-title":"Varicella-zoster virus infection in Australia.","volume":"22","author":"Chant","year":"1998","journal-title":"Aust N Z J Public Health"},{"key":"R8-19-20210202","first-page":"S1","article-title":"Vaccine preventable diseases and immunisation coverage in Australia, 1999-2000.","volume":"26","author":"McIntyre","year":"2002","journal-title":"Commun Dis Intell"},{"key":"R9-19-20210202","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995-2000.","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"key":"R10-19-20210202","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States.","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"key":"R11-19-20210202","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.vaccine.2010.01.036","article-title":"A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia.","volume":"28","author":"Carville","year":"2010","journal-title":"Vaccine"},{"key":"R12-19-20210202","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.vaccine.2004.07.025","article-title":"The burden and cost of hospitalised varicella and zoster in Australian children.","volume":"23","author":"Carapetis","year":"2004","journal-title":"Vaccine"},{"key":"R14-19-20210202","first-page":"A16","article-title":"The development and trial of Paediatric Active Enhanced Disease Surveillance (PAEDS): a new surveillance mechanism for Australia.","volume":"44","author":"Pym","year":"2008","journal-title":"J Paediatr Child Health"},{"key":"R15-19-20210202","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1440-1754.2006.00949.x","article-title":"Case for varicella surveillance in Australia.","volume":"42","author":"Peadon","year":"2006","journal-title":"J Paediatr Child Health"},{"issue":"suppl 1","key":"R16-19-20210202","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/514267","article-title":"Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world.","volume":"178","author":"LaRussa","year":"1998","journal-title":"J Infect Dis"},{"key":"R17-19-20210202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcv.2008.03.027","article-title":"Differentiation between vaccine and wild-type varicella-zoster virus genotypes by high-resolution melt analysis of single nucleotide polymorphisms.","volume":"43","author":"Toi","year":"2008","journal-title":"J Clin Virol"},{"issue":"pt 8","key":"R19-19-20210202","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1099\/jmm.0.019547-0","article-title":"Prevalence of varicella-zoster virus genotypes in Australia characterized by high-resolution melt analysis and ORF22 gene analyses.","volume":"59","author":"Toi","year":"2010","journal-title":"J Med Microbiol"},{"key":"R20-19-20210202","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/vir.0.017814-0","article-title":"A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008.","volume":"91","author":"Breuer","year":"2010","journal-title":"J Gen Virol"},{"key":"R21-19-20210202","first-page":"132","article-title":"Immunisation coverage annual report, 2009.","volume":"35","author":"Hull","year":"2011","journal-title":"Commun Dis Intell"},{"key":"R22-19-20210202","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2334-11-85","article-title":"Hospitalization due to varicella in the Netherlands.","volume":"11","author":"van Lier","year":"2011","journal-title":"BMC Infect Dis"},{"key":"R23-19-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2431-11-31","article-title":"Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis.","volume":"11","author":"Wiegering","year":"2011","journal-title":"BMC Pediatr"},{"key":"R24-19-20210202","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM196208232670801","article-title":"Modification of chickenpox in family contacts by administration of gammaglobulin.","volume":"267","author":"Ross","year":"1962","journal-title":"N Engl J Med"},{"key":"R25-19-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.meegid.2010.08.014","article-title":"Evolution and world-wide distribution of varicella-zoster virus clades.","volume":"11","author":"Schmidt-Chanasit","year":"2011","journal-title":"Infect Genet Evol"},{"key":"R26-19-20210202","doi-asserted-by":"crossref","first-page":"12758","DOI":"10.1128\/JVI.01145-07","article-title":"Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand.","volume":"81","author":"Loparev","year":"2007","journal-title":"J Virol"},{"key":"R27-19-20210202","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1128\/JVI.01067-12","article-title":"The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation.","volume":"86","author":"Peters","year":"2012","journal-title":"JVirol"},{"key":"R28-19-20210202","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice.","volume":"344","author":"Vazquez","year":"2001","journal-title":"N Engl J Med"},{"key":"R29-19-20210202","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Study Group for Varivax. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R31-19-20210202","first-page":"CD001833","article-title":"Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.","volume":"16","author":"Macartney","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R32-19-20210202","first-page":"567","article-title":"Varicella: Efficacy of two-dose immunization in childhood.","volume":"105","author":"Wutzler","year":"2008","journal-title":"Dtsch Arztebl Int"},{"key":"R33-19-20210202","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/jiq052","article-title":"Effectiveness of 2 doses of varicella vaccine in children.","volume":"203","author":"Shapiro","year":"2011","journal-title":"J Infect Dis"},{"key":"R34-19-20210202","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1016\/j.vaccine.2005.05.033","article-title":"Uptake of varicella vaccine-a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation.","volume":"23","author":"Marshall","year":"2005","journal-title":"Vaccine"},{"key":"R35-19-20210202","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1440-1754.2009.01494.x","article-title":"Varicella immunisation practice: Implications for provision of a recommended, non-funded vaccine.","volume":"45","author":"Marshall","year":"2009","journal-title":"J Paediatr Child Health"},{"key":"R36-19-20210202","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4049\/jimmunol.0902817","article-title":"Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instruction.","volume":"185","author":"Gutzeit","year":"2010","journal-title":"J Immunol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e31827e92b7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T16:17:09Z","timestamp":1643905029000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201305000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31827e92b7","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}